Search Results - "Youssif, Bahaa G.M."

Refine Results
  1. 1

    Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents by Hisham, Mohamed, Youssif, Bahaa G.M., Osman, Essam Eldin A., Hayallah, Alaa M., Abdel-Aziz, Mohamed

    Published in European journal of medicinal chemistry (15-08-2019)
    “…A series of novel xanthine/NO donor hybrids containing 1,3,8-trisubstituted or 1,8-disubstituted xanthine derivatives were designed and synthesized. The…”
    Get full text
    Journal Article
  2. 2

    EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules by Abou-Zied, Hesham A., Youssif, Bahaa G.M., Mohamed, Mamdouh F.A., Hayallah, Alaa M., Abdel-Aziz, Mohamed

    Published in Bioorganic chemistry (01-08-2019)
    “…[Display omitted] •A series of 20 novel compounds contain xanthine-chalcone hybrid was designed and synthesized.•The synthesized hybrids were evaluated against…”
    Get full text
    Journal Article
  3. 3

    Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors by Hisham, Mohamed, Hassan, Heba A., Gomaa, Hesham A.M., Youssif, Bahaa G.M., Hayallah, Alaa M., Abdel-Aziz, Mohamed

    Published in Journal of molecular structure (15-04-2022)
    “…•A series of novel quinazoline-4-one/chalcone hybrids as EGFR inhibitors has been designed and synthesized.•Compounds 19, 20, and 22 were the most active…”
    Get full text
    Journal Article
  4. 4

    5-Chlorobenzofuran-2-carboxamides: From allosteric CB1 modulators to potential apoptotic antitumor agents by Youssif, Bahaa G.M., Mohamed, Ashraf M., Osman, Essam Eldin A., Abou-Ghadir, Ola F., Elnaggar, Dina H., Abdelrahman, Mostafa H., Treamblu, Laurent, Gomaa, Hesham A.M.

    Published in European journal of medicinal chemistry (01-09-2019)
    “…Cannabinoids as THC and the CB1 allosteric modulator CBD were reported to have antiproliferative activities with no reports for other CB1 allosteric modulators…”
    Get full text
    Journal Article
  5. 5

    Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance by Zha, Gao-Feng, Qin, Hua-Li, Youssif, Bahaa G.M., Amjad, Muhammad Wahab, Raja, Maria Abdul Ghafoor, Abdelazeem, Ahmed H., Bukhari, Syed Nasir Abbas

    Published in European journal of medicinal chemistry (28-07-2017)
    “…The drug research and development nowadays is focusing on multi-target drugs. In the treatment of cancer, therapies using drugs inhibiting one numerous targets…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Linseed hydrogel-mediated green synthesis of silver nanoparticles for antimicrobial and wound-dressing applications by Haseeb, Muhammad Tahir, Hussain, Muhammad Ajaz, Abbas, Khawar, Youssif, Bahaa Gm, Bashir, Sajid, Yuk, Soon Hong, Bukhari, Syed Nasir Abbas

    Published in International journal of nanomedicine (01-01-2017)
    “…Polysaccharides are being extensively employed for the synthesis of silver nanoparticles (Ag NPs) having diverse morphology and applications. Herein, we…”
    Get full text
    Journal Article
  8. 8

    Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives by Shaykoon, Montaser Sh, Marzouk, Adel A., Soltan, Osama M., Wanas, Amira S., Radwan, Mohamed M., Gouda, Ahmed M., Youssif, Bahaa G.M., Abdel-Aziz, Mohamed

    Published in Bioorganic chemistry (01-07-2020)
    “…[Display omitted] •Two series of 1,2,4-triazole and 1,3,4-oxadiazole derivatives were designed and synthesized.•3a-b and 4a-b showed higher antitrypanosomal…”
    Get full text
    Journal Article
  9. 9

    Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors by Mohamed, Mamdouh F.A., Youssif, Bahaa G.M., Shaykoon, Montaser Sh. A., Abdelrahman, Mostafa H., Elsadek, Bakheet E.M., Aboraia, Ahmed S., Abuo-Rahma, Gamal El-Din A.

    Published in Bioorganic chemistry (01-10-2019)
    “…[Display omitted] •12 novel compounds contain Tetrahydrobenzo[4,5]Thieno[2,3-d]pyrimidinone as a novel cap group, attached to ZBG via aliphatic, aralkyl or…”
    Get full text
    Journal Article
  10. 10

    Novel 1,2,4-oxadiazole/pyrrolidine hybrids as DNA gyrase and topoisomerase IV inhibitors with potential antibacterial activity by Frejat, Firas Obaid Arhema, Cao, Yaquan, Zhai, Hongjin, Abdel-Aziz, Salah A., Gomaa, Hesham A.M., Youssif, Bahaa G.M., Wu, Chunli

    Published in Arabian journal of chemistry (01-01-2022)
    “…DNA gyrase is a promising target for antibacterial agents. Several classes of small-molecule inhibitors have been discovered in recent decades, but none of…”
    Get full text
    Journal Article
  11. 11

    Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities by El-Sherief, Hany A M, Youssif, Bahaa G M, Abdelazeem, Ahmed H, Abdel-Aziz, Mohamed, Abdel-Rahman, Hamdy M

    Published in Anti-cancer agents in medicinal chemistry (01-01-2019)
    “…1,2,4-triazoles possess a broad spectrum of biological activities such as analgesic, antimicrobial, antitubercular, anti-inflammatory and antineoplastic…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases by Mohassab, Aliaa M., Hassan, Heba A., Abdelhamid, Dalia, Gouda, Ahmed M., Youssif, Bahaa G.M., Tateishi, Hiroshi, Fujita, Mikako, Otsuka, Masami, Abdel-Aziz, Mohamed

    Published in Bioorganic chemistry (01-01-2021)
    “…[Display omitted] •A series of quinoline/chalcone/1,2,4-triazole hybrids was synthesized and tested by NCI for their anticancer activity.•7b, 7d, 9b, and 9d…”
    Get full text
    Journal Article
  15. 15

    Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism by Abourehab, Mohammed A S, Alqahtani, Alaa M, Youssif, Bahaa G M, Gouda, Ahmed M

    Published in Molecules (Basel, Switzerland) (04-11-2021)
    “…Targeting the EGFR with small-molecule inhibitors is a confirmed valid strategy in cancer therapy. Since the FDA approval of the first EGFR-TKI, erlotinib,…”
    Get full text
    Journal Article
  16. 16

    Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors by El-Sherief, Hany A.M., Youssif, Bahaa G.M., Abbas Bukhari, Syed Nasir, Abdelazeem, Ahmed H., Abdel-Aziz, Mohamed, Abdel-Rahman, Hamdy M.

    Published in European journal of medicinal chemistry (05-08-2018)
    “…A series of novel compounds carrying 1,2,4-triazole scaffold were prepared and evaluated for their antiproliferative activities against NCI 60 cell line…”
    Get full text
    Journal Article
  17. 17

    Design, synthesis, and antiproliferative properties of new 1,2,3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors by Mahmoud, Mohamed A., Mohammed, Anber F., Salem, Ola I.A., Rabea, Safwat M., Youssif, Bahaa G.M.

    Published in Journal of molecular structure (15-06-2023)
    “…•A series of 1,2,3-triazole-carboximidamide derivatives was designed and synthesised.•The new compounds were evaluated as antiproliferative agent targeting…”
    Get full text
    Journal Article
  18. 18
  19. 19

    New quinoline/1,2,4-triazole hybrids as dual inhibitors of COX-2/5-LOX and inflammatory cytokines: Design, synthesis, and docking study by Mohassab, Aliaa M., Hassan, Heba A., Abdelhamid, Dalia, Gouda, Ahmed M., Gomaa, Hesham A.M., Youssif, Bahaa G.M., Radwan, Mohamed O., Fujita, Mikako, Otsuka, Masami, Abdel-Aziz, Mohamed

    Published in Journal of molecular structure (15-11-2021)
    “…•Novel quinoline/1,2,4-triazole hybrids 6a-i and 7a-j as anti-inflammatory agents has been designed and synthesized.•Compounds 6e, 6i, and 7e showed potent…”
    Get full text
    Journal Article
  20. 20

    Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway by Al-Wahaibi, Lamya H., Mahmoud, Mohamed A., Mostafa, Yaser A., Raslan, Ali E., Youssif, Bahaa G. M.

    “…A new series of piperine-carboximidamide hybrids VIa-k was developed as a new cytotoxic agent targeting EGFR, BRAF, and CDK2. The antiproliferative effect…”
    Get full text
    Journal Article